Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | TCM_Taiwan* | |||
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota |
PMID[12350137] |
|||
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota |
PMID[9584408] |
|||
NPO33471 | Zingiber spectabile | Species | Zingiberaceae | Eukaryota | Rhizomes |
PMID[22546674] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 140000 | nM | 9301668 |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 120000 | nM | 9301668 |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 21360 | nM | 15780608 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | Inhibition | = | 67.8 | % | 15780608 |
NPT325 | Individual Protein | Cyclooxygenase-2 | Ovis aries | Inhibition | = | 31.6 | % | 15780608 |
NPT2 | Others | Unspecified | IC50 | = | 20000 | nM | 18678491 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | CD50 | = | 3.8 | ug/ml | 9868158 |
NPT3701 | Individual Protein | CpG DNA methylase | Spiroplasma monobiae | IC50 | = | 30 | nM | 19112019 |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | ED50 | = | 4 | ug/ml | 12350137 |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | ED50 | = | 5 | ug/ml | 12350137 |
NPT2 | Others | Unspecified | Activity | = | 93.8 | % | 16038556 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 24210 | nM | 16038556 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 50000 | nM | 16038556 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 18510 | nM | 16038556 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 21700 | nM | 16038556 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 25700 | nM | 16038556 |
NPT2 | Others | Unspecified | Inhibition | = | 92.49 | % | 15730265 | |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 4600 | nM | 20004045 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 5900 | nM | 20004045 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 2200 | nM | 20004045 |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 37000 | nM | 20004045 |
NPT842 | Organism | Leishmania mexicana | Leishmania mexicana | EC50 | = | 37000 | nM | 20004045 |
NPT71 | Cell Line | HEK293 | Homo sapiens | EC50 | = | 40000 | nM | 20004045 |
NPT115 | Organism | Mycobacterium tuberculosis H37Ra | Mycobacterium tuberculosis H37Ra | MIC | = | 50 | ug/ml | 20691508 |
NPT2 | Others | Unspecified | Potency | = | 14581 | nM | PubChem BioAssay data set | |
NPT3704 | Individual Protein | Multidrug resistance protein CDR1 | Candida albicans | IC50 | = | 45000 | nM | 19470507 |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT1005 | Individual Protein | Tumor susceptibility gene 101 protein | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT799 | Individual Protein | Intestinal alkaline phosphatase | Mus musculus | IC50 | = | 8380 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT798 | Individual Protein | Alkaline phosphatase placental-like | Homo sapiens | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 29081 | nM | PubChem BioAssay data set | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 18526 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT4252 | Individual Protein | Toll-like receptor 9 | Homo sapiens | IC50 | = | 9127 | nM | PubChem BioAssay data set |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 11689.1 | nM | PubChem BioAssay data set | |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 39345 | nM | PubChem BioAssay data set |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT4253 | Individual Protein | Beta Lactamase | Pseudomonas aeruginosa | IC50 | = | 8095 | nM | PubChem BioAssay data set |
NPT2971 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3F | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 74100 | nM | 22546674 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 48120 | nM | 22546674 |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | IC50 | = | 61410 | nM | 22546674 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | IC50 | = | 24140 | nM | 22546674 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 80020 | nM | 22546674 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 19380 | nM | 22546674 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 75340 | nM | 22546674 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 87470 | nM | 22546674 |
NPT2 | Others | Unspecified | Activity | = | 50.87 | % | 22546674 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 18356.4 | nM | PubChem BioAssay data set | |
NPT477 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3G | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT1417 | Individual Protein | Transcriptional regulator ERG | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT1674 | Individual Protein | CaM kinase II alpha | Homo sapiens | IC50 | = | 24000 | nM | 22989913 |
NPT790 | Organism | Mycobacterium tuberculosis H37Rv | Mycobacterium tuberculosis H37Rv | MIC | = | 200 | ug/ml | 22280816 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 44300 | nM | 23153397 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 58100 | nM | 23153397 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 38100 | nM | 23153397 |
NPT2 | Others | Unspecified | Potency | 25929 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 20596.2 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | IC50 | = | 37740 | nM | 23583510 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 24000 | nM | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 5.02 | U/L | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 7.13 | U/L | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 589 | K/uL | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 485 | K/uL | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 6.83 | K/uL | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 4.69 | K/uL | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 31.1 | % | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 30.6 | % | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.139 | ug | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.129 | ug | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 1.1 | ug | 23145932 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.987 | ug | 23145932 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | > | 50 | % | 23145932 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 48 | % | 23145932 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 53 | % | 23145932 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 57 | % | 23145932 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 51 | % | 23145932 |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | IC50 | = | 1600000 | nM | 24360557 |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | Inhibition | = | 35 | % | 24360557 |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 25118.9 | nM | PubChem BioAssay data set | ||
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | 2667.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 15600 | nM | 24689857 | |
NPT2 | Others | Unspecified | Inhibition | = | 4 | % | 24689857 | |
NPT2 | Others | Unspecified | Inhibition | = | 32 | % | 24689857 | |
NPT2 | Others | Unspecified | Inhibition | = | 46 | % | 24689857 | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 26450 | nM | 24857542 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC189844 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC109083 |
1.0 | High Similarity | NPC269843 |
1.0 | High Similarity | NPC14007 |
1.0 | High Similarity | NPC60962 |
1.0 | High Similarity | NPC224814 |
0.9741 | High Similarity | NPC229084 |
0.9741 | High Similarity | NPC18984 |
0.9741 | High Similarity | NPC160900 |
0.9741 | High Similarity | NPC106659 |
0.9646 | High Similarity | NPC280001 |
0.9496 | High Similarity | NPC276014 |
0.9492 | High Similarity | NPC246704 |
0.9487 | High Similarity | NPC286573 |
0.9417 | High Similarity | NPC123228 |
0.9417 | High Similarity | NPC5018 |
0.9417 | High Similarity | NPC123722 |
0.9417 | High Similarity | NPC276466 |
0.9417 | High Similarity | NPC151167 |
0.9412 | High Similarity | NPC289459 |
0.9339 | High Similarity | NPC110313 |
0.9333 | High Similarity | NPC179777 |
0.9333 | High Similarity | NPC84076 |
0.9333 | High Similarity | NPC303680 |
0.9333 | High Similarity | NPC120225 |
0.9333 | High Similarity | NPC90128 |
0.9333 | High Similarity | NPC213552 |
0.9316 | High Similarity | NPC158949 |
0.9262 | High Similarity | NPC304622 |
0.9224 | High Similarity | NPC272471 |
0.9224 | High Similarity | NPC137537 |
0.9224 | High Similarity | NPC164706 |
0.9224 | High Similarity | NPC70744 |
0.9224 | High Similarity | NPC107588 |
0.9224 | High Similarity | NPC470626 |
0.918 | High Similarity | NPC478215 |
0.9153 | High Similarity | NPC204466 |
0.9138 | High Similarity | NPC39793 |
0.9138 | High Similarity | NPC185738 |
0.9138 | High Similarity | NPC293619 |
0.9106 | High Similarity | NPC83062 |
0.9091 | High Similarity | NPC53305 |
0.9091 | High Similarity | NPC87113 |
0.9091 | High Similarity | NPC257589 |
0.9083 | High Similarity | NPC242372 |
0.9083 | High Similarity | NPC164778 |
0.9083 | High Similarity | NPC4181 |
0.9083 | High Similarity | NPC257976 |
0.9076 | High Similarity | NPC70752 |
0.9068 | High Similarity | NPC2058 |
0.9068 | High Similarity | NPC95614 |
0.9068 | High Similarity | NPC232316 |
0.9068 | High Similarity | NPC165133 |
0.9068 | High Similarity | NPC117780 |
0.9068 | High Similarity | NPC242885 |
0.9068 | High Similarity | NPC56214 |
0.9068 | High Similarity | NPC202474 |
0.9068 | High Similarity | NPC227217 |
0.9032 | High Similarity | NPC66905 |
0.9016 | High Similarity | NPC92207 |
0.9016 | High Similarity | NPC127937 |
0.9008 | High Similarity | NPC60517 |
0.9008 | High Similarity | NPC20443 |
0.9008 | High Similarity | NPC312404 |
0.9008 | High Similarity | NPC273686 |
0.9008 | High Similarity | NPC146886 |
0.9 | High Similarity | NPC114298 |
0.8992 | High Similarity | NPC207613 |
0.8983 | High Similarity | NPC310338 |
0.8983 | High Similarity | NPC281298 |
0.8938 | High Similarity | NPC7097 |
0.8938 | High Similarity | NPC36108 |
0.8938 | High Similarity | NPC233731 |
0.8938 | High Similarity | NPC246358 |
0.8926 | High Similarity | NPC238810 |
0.8917 | High Similarity | NPC38996 |
0.8917 | High Similarity | NPC160380 |
0.8917 | High Similarity | NPC184651 |
0.8917 | High Similarity | NPC470212 |
0.8917 | High Similarity | NPC473853 |
0.8917 | High Similarity | NPC113865 |
0.8917 | High Similarity | NPC54872 |
0.8917 | High Similarity | NPC343720 |
0.8917 | High Similarity | NPC324571 |
0.8917 | High Similarity | NPC312675 |
0.8917 | High Similarity | NPC262156 |
0.8898 | High Similarity | NPC277460 |
0.8889 | High Similarity | NPC268317 |
0.888 | High Similarity | NPC172673 |
0.8879 | High Similarity | NPC294941 |
0.8871 | High Similarity | NPC226661 |
0.8843 | High Similarity | NPC262253 |
0.8843 | High Similarity | NPC473411 |
0.8843 | High Similarity | NPC71579 |
0.8843 | High Similarity | NPC85488 |
0.8814 | High Similarity | NPC86947 |
0.8783 | High Similarity | NPC156840 |
0.8783 | High Similarity | NPC8547 |
0.8783 | High Similarity | NPC257124 |
0.8783 | High Similarity | NPC297657 |
0.8783 | High Similarity | NPC78918 |
0.8783 | High Similarity | NPC173746 |
0.8783 | High Similarity | NPC139617 |
0.877 | High Similarity | NPC163083 |
0.877 | High Similarity | NPC31344 |
0.877 | High Similarity | NPC471693 |
0.877 | High Similarity | NPC317769 |
0.877 | High Similarity | NPC280704 |
0.876 | High Similarity | NPC201777 |
0.875 | High Similarity | NPC61516 |
0.875 | High Similarity | NPC135127 |
0.875 | High Similarity | NPC232084 |
0.875 | High Similarity | NPC247364 |
0.875 | High Similarity | NPC111635 |
0.875 | High Similarity | NPC119060 |
0.875 | High Similarity | NPC10932 |
0.875 | High Similarity | NPC237594 |
0.875 | High Similarity | NPC476387 |
0.875 | High Similarity | NPC249791 |
0.875 | High Similarity | NPC474565 |
0.874 | High Similarity | NPC239302 |
0.8739 | High Similarity | NPC275519 |
0.8739 | High Similarity | NPC212743 |
0.873 | High Similarity | NPC244246 |
0.873 | High Similarity | NPC311419 |
0.873 | High Similarity | NPC123196 |
0.873 | High Similarity | NPC65935 |
0.873 | High Similarity | NPC215941 |
0.873 | High Similarity | NPC319282 |
0.873 | High Similarity | NPC137427 |
0.873 | High Similarity | NPC275724 |
0.8707 | High Similarity | NPC51698 |
0.8699 | High Similarity | NPC74478 |
0.8678 | High Similarity | NPC471877 |
0.8678 | High Similarity | NPC166759 |
0.8678 | High Similarity | NPC470848 |
0.8678 | High Similarity | NPC470849 |
0.8672 | High Similarity | NPC36490 |
0.8672 | High Similarity | NPC327410 |
0.8667 | High Similarity | NPC24474 |
0.8667 | High Similarity | NPC311595 |
0.8667 | High Similarity | NPC299406 |
0.8667 | High Similarity | NPC37858 |
0.8667 | High Similarity | NPC141791 |
0.8667 | High Similarity | NPC263386 |
0.8655 | High Similarity | NPC164386 |
0.8629 | High Similarity | NPC299584 |
0.8629 | High Similarity | NPC271985 |
0.8629 | High Similarity | NPC208950 |
0.8629 | High Similarity | NPC82483 |
0.8629 | High Similarity | NPC472093 |
0.8629 | High Similarity | NPC228771 |
0.8629 | High Similarity | NPC17943 |
0.8629 | High Similarity | NPC251855 |
0.8629 | High Similarity | NPC148627 |
0.8629 | High Similarity | NPC265483 |
0.8629 | High Similarity | NPC233410 |
0.8629 | High Similarity | NPC58279 |
0.8629 | High Similarity | NPC116907 |
0.8629 | High Similarity | NPC300326 |
0.8629 | High Similarity | NPC29008 |
0.8629 | High Similarity | NPC194519 |
0.8629 | High Similarity | NPC266705 |
0.8629 | High Similarity | NPC9067 |
0.8629 | High Similarity | NPC3221 |
0.8629 | High Similarity | NPC298757 |
0.8629 | High Similarity | NPC221077 |
0.8629 | High Similarity | NPC57490 |
0.8629 | High Similarity | NPC193544 |
0.8629 | High Similarity | NPC117214 |
0.8629 | High Similarity | NPC203133 |
0.8629 | High Similarity | NPC475169 |
0.8626 | High Similarity | NPC284409 |
0.8621 | High Similarity | NPC226250 |
0.8618 | High Similarity | NPC197757 |
0.8618 | High Similarity | NPC228922 |
0.8615 | High Similarity | NPC120852 |
0.8615 | High Similarity | NPC90431 |
0.8607 | High Similarity | NPC127389 |
0.8607 | High Similarity | NPC290451 |
0.8594 | High Similarity | NPC245120 |
0.8583 | High Similarity | NPC124916 |
0.8583 | High Similarity | NPC474214 |
0.8583 | High Similarity | NPC474040 |
0.8571 | High Similarity | NPC281277 |
0.8571 | High Similarity | NPC109275 |
0.8561 | High Similarity | NPC474784 |
0.856 | High Similarity | NPC28730 |
0.856 | High Similarity | NPC17837 |
0.856 | High Similarity | NPC214406 |
0.856 | High Similarity | NPC18924 |
0.856 | High Similarity | NPC58607 |
0.856 | High Similarity | NPC274356 |
0.856 | High Similarity | NPC44748 |
0.856 | High Similarity | NPC103823 |
0.856 | High Similarity | NPC223136 |
0.856 | High Similarity | NPC304630 |
0.856 | High Similarity | NPC178284 |
0.856 | High Similarity | NPC78974 |
0.856 | High Similarity | NPC191037 |
0.8559 | High Similarity | NPC33749 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC189844 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9741 | High Similarity | NPD4379 | Clinical (unspecified phase) |
0.9138 | High Similarity | NPD5536 | Phase 2 |
0.8783 | High Similarity | NPD228 | Approved |
0.8475 | Intermediate Similarity | NPD5283 | Phase 1 |
0.8359 | Intermediate Similarity | NPD3027 | Phase 3 |
0.8346 | Intermediate Similarity | NPD9494 | Approved |
0.8136 | Intermediate Similarity | NPD3022 | Approved |
0.8136 | Intermediate Similarity | NPD3021 | Approved |
0.7966 | Intermediate Similarity | NPD1358 | Approved |
0.792 | Intermediate Similarity | NPD1357 | Approved |
0.7891 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7891 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7812 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7788 | Intermediate Similarity | NPD9296 | Approved |
0.7761 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7761 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7761 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7744 | Intermediate Similarity | NPD3145 | Approved |
0.7744 | Intermediate Similarity | NPD3144 | Approved |
0.7731 | Intermediate Similarity | NPD3134 | Approved |
0.773 | Intermediate Similarity | NPD4357 | Discontinued |
0.7727 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7687 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7681 | Intermediate Similarity | NPD7266 | Discontinued |
0.7652 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7652 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7635 | Intermediate Similarity | NPD3882 | Suspended |
0.763 | Intermediate Similarity | NPD1613 | Approved |
0.763 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.763 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7619 | Intermediate Similarity | NPD2801 | Approved |
0.7615 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7603 | Intermediate Similarity | NPD2684 | Approved |
0.7578 | Intermediate Similarity | NPD4626 | Approved |
0.7551 | Intermediate Similarity | NPD1934 | Approved |
0.7537 | Intermediate Similarity | NPD7095 | Approved |
0.75 | Intermediate Similarity | NPD7843 | Approved |
0.7482 | Intermediate Similarity | NPD2935 | Discontinued |
0.7478 | Intermediate Similarity | NPD2934 | Approved |
0.7478 | Intermediate Similarity | NPD2933 | Approved |
0.746 | Intermediate Similarity | NPD7157 | Approved |
0.7447 | Intermediate Similarity | NPD3060 | Approved |
0.7438 | Intermediate Similarity | NPD968 | Approved |
0.7424 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7414 | Intermediate Similarity | NPD2860 | Approved |
0.7414 | Intermediate Similarity | NPD2859 | Approved |
0.7397 | Intermediate Similarity | NPD1653 | Approved |
0.7394 | Intermediate Similarity | NPD8166 | Discontinued |
0.7385 | Intermediate Similarity | NPD3847 | Discontinued |
0.7385 | Intermediate Similarity | NPD3496 | Discontinued |
0.7383 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7373 | Intermediate Similarity | NPD3020 | Approved |
0.7364 | Intermediate Similarity | NPD1651 | Approved |
0.7361 | Intermediate Similarity | NPD1511 | Approved |
0.736 | Intermediate Similarity | NPD5535 | Approved |
0.7353 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7353 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7353 | Intermediate Similarity | NPD5109 | Approved |
0.7343 | Intermediate Similarity | NPD6190 | Approved |
0.7333 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD3705 | Approved |
0.7323 | Intermediate Similarity | NPD6671 | Approved |
0.7319 | Intermediate Similarity | NPD447 | Suspended |
0.7313 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7302 | Intermediate Similarity | NPD1241 | Discontinued |
0.7273 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7273 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7273 | Intermediate Similarity | NPD3972 | Approved |
0.7273 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD2492 | Phase 1 |
0.726 | Intermediate Similarity | NPD1512 | Approved |
0.7258 | Intermediate Similarity | NPD5451 | Approved |
0.725 | Intermediate Similarity | NPD291 | Approved |
0.7236 | Intermediate Similarity | NPD290 | Approved |
0.7231 | Intermediate Similarity | NPD5691 | Approved |
0.723 | Intermediate Similarity | NPD3866 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD3455 | Phase 2 |
0.723 | Intermediate Similarity | NPD824 | Approved |
0.7226 | Intermediate Similarity | NPD6798 | Discontinued |
0.7226 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7211 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7203 | Intermediate Similarity | NPD4162 | Approved |
0.7194 | Intermediate Similarity | NPD4340 | Discontinued |
0.7194 | Intermediate Similarity | NPD6355 | Discontinued |
0.7194 | Intermediate Similarity | NPD230 | Phase 1 |
0.7181 | Intermediate Similarity | NPD7028 | Phase 2 |
0.7179 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7176 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7176 | Intermediate Similarity | NPD5846 | Approved |
0.7174 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7174 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7171 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7164 | Intermediate Similarity | NPD1283 | Approved |
0.7164 | Intermediate Similarity | NPD1876 | Approved |
0.7132 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7122 | Intermediate Similarity | NPD943 | Approved |
0.7122 | Intermediate Similarity | NPD1240 | Approved |
0.7105 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7103 | Intermediate Similarity | NPD5241 | Discontinued |
0.7099 | Intermediate Similarity | NPD5585 | Approved |
0.7092 | Intermediate Similarity | NPD6896 | Approved |
0.7092 | Intermediate Similarity | NPD6895 | Approved |
0.709 | Intermediate Similarity | NPD6582 | Phase 2 |
0.709 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7089 | Intermediate Similarity | NPD3818 | Discontinued |
0.7083 | Intermediate Similarity | NPD4237 | Approved |
0.7083 | Intermediate Similarity | NPD4236 | Phase 3 |
0.708 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7075 | Intermediate Similarity | NPD4123 | Phase 3 |
0.7071 | Intermediate Similarity | NPD1933 | Approved |
0.7068 | Intermediate Similarity | NPD422 | Phase 1 |
0.7068 | Intermediate Similarity | NPD1535 | Discovery |
0.7063 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7059 | Intermediate Similarity | NPD2798 | Approved |
0.705 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD2668 | Approved |
0.7045 | Intermediate Similarity | NPD2667 | Approved |
0.7044 | Intermediate Similarity | NPD7054 | Approved |
0.7042 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7042 | Intermediate Similarity | NPD2799 | Discontinued |
0.7039 | Intermediate Similarity | NPD2977 | Approved |
0.7039 | Intermediate Similarity | NPD2978 | Approved |
0.7034 | Intermediate Similarity | NPD6331 | Phase 2 |
0.7023 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7023 | Intermediate Similarity | NPD1894 | Discontinued |
0.7021 | Intermediate Similarity | NPD1607 | Approved |
0.7015 | Intermediate Similarity | NPD2233 | Approved |
0.7015 | Intermediate Similarity | NPD2232 | Approved |
0.7015 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7015 | Intermediate Similarity | NPD2230 | Approved |
0.7014 | Intermediate Similarity | NPD2424 | Discontinued |
0.7007 | Intermediate Similarity | NPD5297 | Approved |
0.7 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7 | Intermediate Similarity | NPD7472 | Approved |
0.6993 | Remote Similarity | NPD3539 | Phase 1 |
0.6991 | Remote Similarity | NPD111 | Approved |
0.6987 | Remote Similarity | NPD2821 | Approved |
0.6986 | Remote Similarity | NPD2219 | Phase 1 |
0.6985 | Remote Similarity | NPD2797 | Approved |
0.6985 | Remote Similarity | NPD3053 | Approved |
0.6985 | Remote Similarity | NPD1203 | Approved |
0.6985 | Remote Similarity | NPD3055 | Approved |
0.6978 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD3268 | Approved |
0.6968 | Remote Similarity | NPD6234 | Discontinued |
0.6966 | Remote Similarity | NPD5177 | Phase 3 |
0.6966 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD1669 | Approved |
0.6962 | Remote Similarity | NPD2898 | Approved |
0.6954 | Remote Similarity | NPD4380 | Phase 2 |
0.6953 | Remote Similarity | NPD821 | Approved |
0.6953 | Remote Similarity | NPD9379 | Approved |
0.6953 | Remote Similarity | NPD9377 | Approved |
0.695 | Remote Similarity | NPD3657 | Discovery |
0.6944 | Remote Similarity | NPD2344 | Approved |
0.6943 | Remote Similarity | NPD6232 | Discontinued |
0.694 | Remote Similarity | NPD1281 | Approved |
0.694 | Remote Similarity | NPD1610 | Phase 2 |
0.6935 | Remote Similarity | NPD9697 | Approved |
0.6934 | Remote Similarity | NPD4624 | Approved |
0.6929 | Remote Similarity | NPD9280 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6028 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6029 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD709 | Approved |
0.6918 | Remote Similarity | NPD7473 | Discontinued |
0.6917 | Remote Similarity | NPD1778 | Approved |
0.6914 | Remote Similarity | NPD7685 | Pre-registration |
0.6912 | Remote Similarity | NPD5311 | Approved |
0.6912 | Remote Similarity | NPD5310 | Approved |
0.6912 | Remote Similarity | NPD3225 | Approved |
0.6908 | Remote Similarity | NPD6873 | Phase 2 |
0.6908 | Remote Similarity | NPD6386 | Approved |
0.6908 | Remote Similarity | NPD6385 | Approved |
0.6901 | Remote Similarity | NPD6653 | Approved |
0.6901 | Remote Similarity | NPD2653 | Approved |
0.6897 | Remote Similarity | NPD4664 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD9295 | Approved |
0.6894 | Remote Similarity | NPD9545 | Approved |
0.6894 | Remote Similarity | NPD1182 | Approved |
0.6892 | Remote Similarity | NPD6799 | Approved |
0.6891 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.6889 | Remote Similarity | NPD1608 | Approved |
0.6889 | Remote Similarity | NPD2337 | Clinical (unspecified phase) |
0.6889 | Remote Similarity | NPD2235 | Phase 2 |
0.6889 | Remote Similarity | NPD2231 | Phase 2 |
0.6887 | Remote Similarity | NPD7458 | Discontinued |
0.6887 | Remote Similarity | NPD3111 | Phase 1 |
0.6879 | Remote Similarity | NPD4140 | Approved |
0.6879 | Remote Similarity | NPD5837 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD6032 | Approved |
0.6875 | Remote Similarity | NPD2161 | Phase 2 |
0.6871 | Remote Similarity | NPD2354 | Approved |
0.6863 | Remote Similarity | NPD37 | Approved |
0.6857 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6853 | Remote Similarity | NPD4536 | Approved |
PubChem CID   | 5324476 |
ChEMBL   | CHEMBL179512 |
ZINC   |
Molecular Weight:   | 338.12 |
ALogP:   | -0.6093 |
MLogP:   | 3.11 |
XLogP:   | 3.61 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 25 |